Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
Titel:
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
Auteur:
Khasraw, M. Pavlakis, N. McCowatt, S. Underhill, C. Begbie, S. de Souza, P. Boyce, A. Parnis, F. Lim, V. Harvie, R. Marx, G.